BRIEF-Medicinova announces positive findings from completed trial of MN-166 research
February 06, 2017 at 18:07 PM EST
* Medicinova announces positive findings from completed trial of MN-166 (ibudilast) in methamphetamine dependence presented at the 50th winter conference on brain research Source text for Eikon: Further company coverage:
